Parenteral Nutrition Market Report 2025

The parenteral nutrition market size has grown strongly in recent years. It will grow from $6.77 billion in 2024 to $7.16 billion in 2025 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to rising disposable income and urbanization, a growing obese population, and the increasing popularity of noninvasive and minimally invasive aesthetic procedures.

The parenteral nutrition market size is expected to see strong growth in the next few years. It will grow to $9.21 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to the increasing elderly population, rapid urbanization and rise in disposable income, and increase in mergers and acquisitions. Major trends in the forecast period include product innovations, the use of artificial intelligence in aesthetics, the development of focal radio frequency technology, the use of laser-assisted liposuction, and partnerships and collaborations.

The rising prevalence of malnutrition worldwide is propelling the growth of the parenteral nutrition market. Malnutrition encompasses deficiencies, excesses, or imbalances in a person's intake of energy or nutrients. The increase in premature births, which leads to immune dysfunction and inadequate nutrition, has heightened the demand for parenteral nutrition among children and infants. For instance, in May 2023, the United Nations International Children's Emergency Fund (UNICEF), a U.S.-based organization, reported that nearly half of all deaths in children under five can be attributed to undernutrition. Undernutrition increases the risk of death from common infections, heightens the frequency and severity of such infections, and delays recovery. Therefore, the escalating prevalence of malnutrition globally is anticipated to significantly boost the demand for parenteral nutrition in the coming years.

The rising birth rate is projected to drive the growth of the parenteral nutrition market in the coming years. The birth rate is defined as the number of live births in the general population per 1,000 people annually. An increase in birth rates and fertility rates is a significant indicator of a growing malnutrition burden among women of childbearing age and new mothers, which in turn boosts the demand for parenteral nutrition. For instance, in July 2022, the United Nations published the 27th edition of the World Population Prospects, indicating that the U.S. birth rate reached 12.012 births per 1,000 people, marking an increase of 0.09%. Consequently, the rising birth rate is expected to enhance the growth of the parenteral nutrition market.

Product innovation stands out as a prominent trend in the parenteral nutrition market. Companies in this market are introducing innovative products, such as the four-oil lipid injectable emulsion, to diversify their parenteral nutrition portfolios. For example, in March 2022, Fresenius Kabi received approval from the US FDA for SMOFlipid lipid injectable emulsion, the first and only four-oil lipid injectable emulsion containing soybean oil, medium-chain triglycerides, olive oil, and fish oil. This product, beneficial for its omega-3 fatty acids, is suitable for pediatric parenteral nutrition, including term and preterm neonates, in both hospital and home care settings.

Companies in the parenteral nutrition market are also concentrating on the introduction of glass packaging systems featuring innovative technologies such as SG EZ-fill packaging technology. Glass packaging systems, known for their chemical inertness and ease of sterilization, guarantee prolonged sterility while safeguarding the physical integrity of the product. In March 2022, SGD Pharma introduced ready-to-use sterile 100 ml Type 1 molded glass vials in SG EZ-fill packaging technology for aseptic fill/finish of parenteral products. The advantages of SG EZ-fill packaging technology include minimal glass-to-glass contact, reducing particle generation to ensure patient safety and minimizing the risk of contamination.

In May 2022, Fresenius Kabi, a Germany-based healthcare company specializing in lifesaving medicines and technologies, acquired Ivenix Inc. for an undisclosed amount. This strategic acquisition aims to enhance Fresenius Kabi's portfolio in the U.S. by integrating Ivenix's advanced infusion systems, thereby strengthening its offerings in the infusion therapies market. Ivenix, Inc. is a U.S.-based medical technology company focused on developing advanced infusion management systems.

Major companies operating in the parenteral nutrition market include Fresenius Kabi, Baxter International Inc., B. Braun Melsungen AG, ICU Medical, Inc., Grifols, S.A., Otsuka Pharmaceutical Co., Ltd., Claris Lifesciences Limited, Sichuan Kelun Pharmaceutical Co., Ltd., JW Pharmaceuticals, Meiji Holdings Co., Ltd., Aculife Healthcare Pvt. Ltd., Aspen Pharmacare, Fresenius SE & Co. KGaA, Ajinomoto Co., Inc., Braun Medical Inc., Laboratoires Aguettant, AnazaoHealth Corporation, Baxter Healthcare Corporation, BioScrip, Inc., Sichuan Pharmaceutical Co., United Pharmaceuticals, HOPES Pharmaceuticals, Braun Medical Ltd, Calea UK.

North America was the largest region in the parenteral nutrition market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the parenteral nutrition market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the parenteral nutrition market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

Parenteral nutrition involves delivering a specific type of food intravenously, as outlined in the field of medicine. The primary goal of this therapy is to correct or prevent malnutrition. It entails administering nutrients directly into a vein. Timely achievement of a well-balanced nutritional intake is crucial for addressing complications and plays a significant role in a patient's recovery.

The key components utilized in parenteral nutrition comprise amino acids, fats, carbohydrates, trace elements, vitamins, minerals, and other elements. Amino acids-based parenteral nutrition pertains to products derived from amino acids for parenteral nutrition. Amino acids serve as a fundamental element in complete parenteral nutrition prescriptions, supporting functions such as cell, organ, skeletal, and respiratory muscle functions, as well as wound healing. These are applicable to adults, children, and newborns in various healthcare settings, including hospitals, clinics, home care, and other end-users.

The parenteral nutrition market research report is one of a series of new reports that provides parenteral nutrition market statistics, including parenteral nutrition industry global market size, regional shares, competitors with a parenteral nutrition market share, detailed parenteral nutrition market segments, market trends and opportunities, and any further data you may need to thrive in the parenteral nutrition industry. This parenteral nutrition market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The parenteral nutrition market includes revenues earned by entities by infusing a specialized form of food through a vein. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.